Cargando…
Analgesia for neuropathic pain by dorsal root ganglion transplantation of genetically engineered mesenchymal stem cells: initial results
BACKGROUND: Cell-based therapy may hold promise for treatment of chronic pain. Mesenchymal stem cells (MSCs) are readily available and robust, and their secretion of therapeutic peptides can be enhanced by genetically engineering. We explored the analgesic potential of transplanting bone marrow-deri...
Autores principales: | Yu, Hongwei, Fischer, Gregory, Ebert, Allison D, Wu, Hsiang-En, Bai, Xiaowen, Hogan, Quinn H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331376/ https://www.ncbi.nlm.nih.gov/pubmed/25888914 http://dx.doi.org/10.1186/s12990-015-0002-9 |
Ejemplares similares
-
Lentiviral gene transfer into the dorsal root ganglion of adult rats
por: Yu, Hongwei, et al.
Publicado: (2011) -
The upregulation of EGFR in the dorsal root ganglion contributes to chronic compression of dorsal root ganglions-induced neuropathic pain in rats
por: Wang, Shuo, et al.
Publicado: (2019) -
Sustained relief of neuropathic pain by AAV-targeted expression of CBD3 peptide in rat dorsal root ganglion
por: Fischer, G, et al.
Publicado: (2014) -
Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain
por: Yu, Xiaobing, et al.
Publicado: (2020) -
The dorsal root ganglion as a target for neurorestoration in neuropathic pain
por: Estivill-Torrús, Guillermo, et al.
Publicado: (2023)